Creotech stock news
On October 26, 2026, Noble Securities published an analytical report on Creotech Instruments S.A. (WSE: CRI) under the Warsaw Stock Exchange Analytical Coverage Support Programme, maintaining a "Hold" recommendation with a 12--month target price of PLN 914.00 per share (against a trading price of PLN 847.00). In its third--quarter 2026 forecast, the brokerage noted that because Creotech did not bill any invoices under the Mikroglob project during Q3, recognized revenue will primarily reflect execution progress on the CAMILA project. Noble Securities forecasts Q3 2026 sales revenue of PLN 28.3 million (+37% YoY), while higher scaling expenses are expected to yield an adjusted EBITDA of --PLN 4.9 million and a net loss of --PLN 8.1 million. The company is scheduled to publish its official Q3 2026 financial report on November 26, 2026.